Accuracy of grading of urothelial carcinoma on urine cytology: An analysis of interobserver and intraobserver agreement

International Journal of Clinical and Experimental Pathology

Volumn 5, Issue 9, 2012, Pages 882-891

  Reid, Michelle D ^a   Osunkoya, Adeboye O ^a   Siddiqui, Momin T ^a   Looney, Stephen W ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Accuracy of grading; Urine cytology; Urothelial carcinoma

Indexed keywords

AGED; ARTICLE; BIOPSY; CANCER GRADING; CARCINOMA; CYTODIAGNOSIS; CYTOLOGY; FEMALE; HUMAN; MALE; METHODOLOGY; OBSERVER VARIATION; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; URINALYSIS; URINARY TRACT CANCER; URINE; UROTHELIUM;

AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA; CYTODIAGNOSIS; FEMALE; HUMANS; MALE; NEOPLASM GRADING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; URINALYSIS; URINE; UROLOGIC NEOPLASMS; UROTHELIUM;

EID: 84870474018     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Papanicolaou GN and Marshall VF. Urine Sediment Smears as a Diagnostic Procedure in Cancers of the Urinary Tract. Science 1945; 101: 519-520.
2. Forte JD, Croker BP and Hendricks JB. Comparison of histologic and cytologic specimens of urothelial carcinoma with image analysis. Implications for grading. Anal Quant Cytol Histol 1997; 19: 158-166.
3. Brown FM. Urine cytology. It is still the gold standard for screening? Urol Clin North Am 2000; 27: 25-37.
4. Curry JL and Wojcik EM. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Cancer 2002; 96: 140-145.
5. Sullivan PS, Nooraie F, Sanchez H, Hirschowitz S, Levin M, Rao PN and Rao J. Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study. Cancer 2009; 117: 167-173.
6. Whisnant RE, Bastacky SI and Ohori NP. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and lowgrade carcinoma) in the context of the 1998 WHO/ISUP classification. Diagn Cytopathol 2003; 28: 186-190.
7. Chu YC, Han JY, Han HS, Kim JM and Suh JK. Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings. Acta Cytol 2002; 46: 341-348.
8. Wiener HG, Vooijs GP and van't Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993; 37: 163-169.
9. Tetu B, Tiguert R, Harel F and Fradet Y. ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma. Mod Pathol 2005; 18: 83-89.
10. Soyuer I, Tokat F and Tasdemir A. Significantly increased accuracy of urothelial carcinoma detection in destained urine slides with combined analysis of standard cytology and CK-20 immunostaing. Acta Cytol 2009; 53: 357-360.
11. Righi E, Rossi G, Ferrari G, Dotti A, De Gaetani C, Ferrari P and Trentini GP. Does p53 immunostaining improve diagnostic accuracy in urine cytology? Diagn Cytopathol 1997; 17: 436-439.
12. Wild PJ, Fuchs T, Stoehr R, Zimmermann D, Frigerio S, Padberg B, Steiner I, Zwarthoff EC, Burger M, Denzinger S, Hofstaedter F, Kristiansen G, Hermanns T, Seifert HH, Provenzano M, Sulser T, Roth V, Buhmann JM, Moch H and Hartmann A. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis. Cancer Epidemiol Biomarkers Prev 2009; 18: 1798-1806.
13. Sokolova IA, Halling KC, Jenkins RB, Burkhardt HM, Meyer RG, Seelig SA and King W. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2000; 2: 116-123.
14. Reid-Nicholson MD, Motiwala N, Drury SC, Peiper SC, Terris MK, Waller JL and Ramalingam P. Chromosomal abnormalities in renal cell carcinoma variants detected by Urovysion fluorescence in situ hybridization on paraffinembedded tissue. Ann Diagn Pathol 2011; 15: 37-45.
15. Reid-Nicholson MD, Ramalingam P, Adeagbo B, Cheng N, Peiper SC and Terris MK. The use of Urovysion fluorescence in situ hybridization in the diagnosis and surveillance of non-urothelial carcinoma of the bladder. Mod Pathol 2009; 22: 119-127.
16. Lopez-Beltran ASG, Gasser T, et al. Tumors of the Urinary System. In: Eble JNSG, Epstein JI, Sesterhenn IA, editors. World Health Organization Classification of Tumours. Pathology and Genetics> Tumors of the Urinary Sytem and Male Genital Organs. Lyon, France: IARC Press; 2004. p. 89-109.
17. Byrt T, Bishop J and Carlin JB. Bias, prevalence and kappa. J Clin Epidemiol 1993; 46: 423-429.
18. Donner A, Shoukri MM, Klar N and Bartfay E. Testing the equality of two dependent kappa statistics. Stat Med 2000; 19: 373-387.
19. Lehmann E. Nonparametrics: Statistical Methods Based on Ranks. San Francisco: Holden-Day, 1975.
20. Landis JR and Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
21. Broders AC. Epithelioma of the Genito-Urinary Organs. Ann Surg 1922; 75: 574-604.
22. Bergkvist A, Ljungqvist A and Moberger G. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinicalpathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-378.
23. Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladder tumors. In: editors. World Health Organization. Geneva: p. 1973.
24. Pauwels RP, Schapers RF, Smeets AW, Debruyne FM and Geraedts JP. Grading in superficial bladder cancer. (1). Morphological criteria. Br J Urol 1988; 61: 129-134.
25. Epstein JI, Amin MB, Reuter VR and Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-1448.
26. Ooms EC, Anderson WA, Alons CL, Boon ME and Veldhuizen RW. Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 1983; 14: 140-143.
27. Ooms EC, Kurver PH, Veldhuizen RW, Alons CL and Boon ME. Morphometric grading of bladder tumors in comparison with histologic grading by pathologists. Hum Pathol 1983; 14: 144-150.
28. Tosoni I, Wagner U, Sauter G, Egloff M, Knonagel H, Alund G, Bannwart F, Mihatsch MJ, Gasser TC and Maurer R. Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer. BJU Int 2000; 85: 48-53.
29. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL and Bostwick DG. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 2000; 88: 1663-1670.
30. Campbell PA, Conrad RJ, Campbell CM, Nicol DL and MacTaggart P. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome. BJU Int 2004; 93: 1228-1231.
31. Cheng L, Neumann RM, Weaver AL, Cheville JC, Leibovich BC, Ramnani DM, Scherer BG, Nehra A, Zincke H and Bostwick DG. Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. Am J Clin Pathol 2000; 113: 275-279.
32. Engers R. Reproducibility and reliability of tumor grading in urological neoplasms. World J Urol 2007; 25: 595-605.
33. Eble JN, Sauter G, Epstein JL and Sesterhenn IA. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2004.
34. Cao D, Vollmer RT, Luly J, Jain S, Roytman TM, Ferris CW and Hudson MA. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. Urology 2010; 76: 593-599.
35. Kruger S, Thorns C, Bohle A and Feller AC. Prognostic significance of a grading system considering tumor heterogeneity in muscle-invasive urothelial carcinoma of the urinary bladder. Int Urol Nephrol 2003; 35: 169-173.
36. Rubben H, Bubenzer J, Bokenkamp K, Lutzeyer W and Rathert P. Grading of transitional cell tumours of the urinary tract by urinary cytology. Urol Res 1979; 7: 83-91.
37. Vom Dorp F, Pal P, Tschirdewahn S, Rossi R, Borgermann C, Schenck M, Becker M, Szarvas T, Hakenberg OW and Rubben H. Correlation of pathological and cytological-cytometric grading of transitional cell carcinoma of the urinary tract. Urol Int 2011; 86: 36-40.
38. Wojcik EM, Miller MC, O'Dowd GJ and Veltri RW. Value of computer-assisted quantitative nuclear grading in differentiation of normal urothelial cells from low and high grade transitional cell carcinoma. Anal Quant Cytol Histol 1998; 20: 69-76.
39. Raab SS, Lenel JC and Cohen MB. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer 1994; 74: 1621-1626.
40. Renshaw AA, Nappi D and Weinberg DS. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine. Acta Cytol 1996; 40: 676-682.